2012 - SPIE Fellow
The scientist’s investigation covers issues in Photodynamic therapy, Antimicrobial, Microbiology, Photosensitizer and Reactive oxygen species. His study in Photodynamic therapy is interdisciplinary in nature, drawing from both Cancer, Cancer research, Singlet oxygen, Immunology and Pathology. His work carried out in the field of Antimicrobial brings together such families of science as Infectious disease and Multiple drug resistance, Antibiotics, Antibiotic resistance, Drug resistance.
The Microbiology study combines topics in areas such as Pseudomonas aeruginosa, Wound healing, In vivo and Staphylococcus aureus. His research in Photosensitizer intersects with topics in Efflux, Biochemistry, Candida albicans, Rose bengal and Methylene blue. His Reactive oxygen species research includes elements of Inflammation, Adenosine triphosphate, Membrane potential, Pharmacology and Mitochondrion.
His main research concerns Photodynamic therapy, Antimicrobial, Microbiology, Photosensitizer and Cancer research. The various areas that Michael R. Hamblin examines in his Photodynamic therapy study include Singlet oxygen, Reactive oxygen species, Immune system, Pathology and Photochemistry. His Immune system study combines topics from a wide range of disciplines, such as Cytotoxic T cell and Antigen.
His Antimicrobial study combines topics in areas such as Escherichia coli, Antibiotics, Antibiotic resistance and Candida albicans. His research in Microbiology tackles topics such as In vivo which are related to areas like In vitro. His Photosensitizer research incorporates themes from Cationic polymerization and Biochemistry.
Michael R. Hamblin mainly investigates Cancer research, microRNA, Nanotechnology, Cancer and Cancer cell. Michael R. Hamblin has included themes like Wnt signaling pathway, Apoptosis, Immune system, Immunotherapy and Metastasis in his Cancer research study. His study with Immune system involves better knowledge in Immunology.
His microRNA study integrates concerns from other disciplines, such as Carcinogenesis, Epigenetics, Long non-coding RNA and Bioinformatics. As a member of one scientific family, he mostly works in the field of Nanotechnology, focusing on Biocompatibility and, on occasion, Graphene and Gene delivery. Michael R. Hamblin usually deals with Cancer and limits it to topics linked to Clinical trial and Medical physics.
His scientific interests lie mostly in microRNA, Cancer research, Coronavirus disease 2019, Cancer and Nanotechnology. The study incorporates disciplines such as Receptor, Epigenetics, Bioinformatics and Cell biology in addition to microRNA. His study in Cancer research is interdisciplinary in nature, drawing from both Autophagy, Apoptosis, Combination therapy and Caspase 8.
His biological study spans a wide range of topics, including Proinflammatory cytokine, Cell binding and 2019-20 coronavirus outbreak. His research integrates issues of Clinical trial and Photodynamic therapy in his study of Cancer. His Nanotechnology research is multidisciplinary, incorporating elements of Wound healing and Low dose.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Photodynamic therapy of cancer: An update†‡
Patrizia Agostinis;Kristian Berg;Keith A. Cengel;Thomas H. Foster.
CA: A Cancer Journal for Clinicians (2011)
Photodynamic therapy and anti-tumour immunity
Ana P. Castano;Pawel Mroz;Michael R. Hamblin;Michael R. Hamblin.
Nature Reviews Cancer (2006)
Photodynamic therapy: a new antimicrobial approach to infectious disease?
Michael R. Hamblin;Tayyaba Hasan.
Photochemical and Photobiological Sciences (2004)
Mechanisms in photodynamic therapy: part one—-photosensitizers, photochemistry and cellular localization
Ana P. Castano;Tatiana N. Demidova;Tatiana N. Demidova;Michael R. Hamblin.
Photodiagnosis and Photodynamic Therapy (2004)
The Nuts and Bolts of Low-level Laser (Light) Therapy
Hoon Chung;Tianhong Dai;Sulbha K. Sharma;Ying-Ying Huang;Ying-Ying Huang.
Annals of Biomedical Engineering (2012)
Biphasic Dose Response in Low Level Light Therapy
Ying-Ying Huang;Aaron C.-H. Chen;James D. Carroll;Michael R. Hamblin.
New photosensitizers for photodynamic therapy
Heidi Abrahamse;Michael R. Hamblin;Michael R. Hamblin.
Biochemical Journal (2016)
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Mahdi Karimi;Amir Ghasemi;Parham Sahandi Zangabad;Reza Rahighi.
Chemical Society Reviews (2016)
Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects
Tianhong Dai;Masamitsu Tanaka;Ying-Ying Huang;Michael R Hamblin.
Expert Review of Anti-infective Therapy (2011)
Photodynamic therapy for localized infections--state of the art.
Tianhong Dai;Ying-Ying Huang;Ying-Ying Huang;Michael R. Hamblin;Michael R. Hamblin.
Photodiagnosis and Photodynamic Therapy (2009)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: